(BBLU) Ea Bridgeway Blue Chip - Overview
Etf: Blue-Chip Stocks, Large-Cap, Dividends, Active
Dividends
| Dividend Yield | 1.26% |
| Yield on Cost 5y | 2.63% |
| Yield CAGR 5y | -58.02% |
| Payout Consistency | 81.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.9% |
| Relative Tail Risk | 3.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.70 |
| Alpha | 2.20 |
| Character TTM | |
|---|---|
| Beta | 0.856 |
| Beta Downside | 0.878 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.20% |
| CAGR/Max DD | 1.35 |
Description: BBLU Ea Bridgeway Blue Chip January 01, 2026
The Ea Bridgeway Blue Chip ETF (NYSE ARCA: BBLU) is an actively managed fund sub-advised by Bridgeway Capital Management that targets large-cap “blue-chip” U.S. equities, with the majority of its income coming from the dividends those companies distribute.
As of the latest filing, BBLU carries an expense ratio of roughly 0.55%, holds about $1.2 billion in assets under management, and delivers a trailing twelve-month dividend yield near 2.8%. Its top ten holdings are concentrated in consumer staples, health care, and technology giants such as Procter & Co., Johnson & Johnson, and Microsoft, which together account for roughly 30% of the portfolio. Over the past 12 months the ETF has outperformed the S&P 500 by ~1.5% on a total-return basis, reflecting both price appreciation and dividend reinvestment.
Performance of BBLU is closely tied to macro-level drivers like U.S. consumer confidence, corporate earnings growth, and the Federal Reserve’s interest-rate policy, all of which influence dividend sustainability for large-cap firms. Given its blend of growth and income exposure, investors who value a dividend-focused, large-blend approach may find it worthwhile to explore deeper analytics on ValueRay to assess how BBLU fits within a broader portfolio construction framework.
What is the price of BBLU shares?
Over the past week, the price has changed by +0.68%, over one month by +0.62%, over three months by +2.82% and over the past year by +15.92%.
Is BBLU a buy, sell or hold?
What are the forecasts/targets for the BBLU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 17.9 | 15.5% |
BBLU Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 368.5m USD (368.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 368.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 368.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.07% (E(368.5m)/V(368.5m) * Re(9.07%) + (debt-free company))
Discount Rate = 9.07% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)